Soybean protein isolate (SPI)

Soybean protein isolate (SPI) is a highly refined protein fraction derived from defatted soybean flakes, containing a minimum protein concentration of 90% on a moisture-free basis. It is not a single molecular target but a complex mixture of storage globulins, primarily glycinin (11S) and beta-conglycinin (7S) (Utsumi et al., 1997). SPI is extensively studied for its nutraceutical properties, particularly its ability to lower serum LDL cholesterol and triglycerides, which led to an FDA-approved heart health claim for soy protein (FDA, 1999). Its biological effects are largely mediated by bioactive peptides released during gastrointestinal digestion, which can modulate lipid metabolism pathways and inhibit enzymes like ACE. Clinically, SPI is used as a dietary intervention for hyperlipidemia and as a high-quality protein source in medical nutrition. However, it is a significant allergen and can clinically interfere with the absorption of medications such as levothyroxine, requiring careful timing of administration (Bell & Osterman, 2001).

Other names

Soy protein isolateIsolated soy proteinSoy protein

Soybean protein isolate acts primarily through its bioactive peptides and its ability to sequester bile acids in the intestine, leading to increased hepatic cholesterol conversion. It upregulates the expression of low-density lipoprotein (LDL) receptors in the liver, enhancing the clearance of LDL cholesterol from the blood (Sirtori et al., 1995). Additionally, digested soy peptides can act as competitive inhibitors of angiotensin-converting enzyme (ACE), contributing to blood pressure reduction (Gibbs et al., 2004).